CClinicalTrials.gg
Not yet recruitingNCT07376668Updated Feb 3, 2026

Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery

An interventional study of Intervention and Standard care in Colorectal Cancer (Diagnosis), sponsored by Tseung Kwan O Hospital, Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-03.

Sponsored by Tseung Kwan O Hospital, Hong Kong · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goals of this study is to evaluate the feasibility and the effects of a WhatsApp-assisted prehabilitation for colorectal cancer patients undergoing elective surgery. The main questions are: If the digital prehabilitation is feasible and acceptable by the colorectal cancer patient prior to elective surgery? If this prehabilitation helps to improve the postoperative complications, length of stay, physical activity and psychological well-being for colorectal cancer patients receiving surgery.

Researcher will compare the prehabilitation plus standard care to standard care only to see if the prehabiliation helps the colorectal cancer patients.

Participants will: 1) enrolled in a approximate 4 weeks (3 episodes/ week) prehabilitation program containing educational information of colorectal cancer, dietary advice, exercises training and psychological podcasting. 2) will answer the survey weekly and after surgery. 3) keep the standard care as per department guidelines

Read the detailed description

Colorectal cancer ranks the second most prevalent forms of cancer in Hong Kong and surgery is still the primary curative option. Although compromising result of shorten general length of stay (LOS) in enhanced recovery after surgery (ERAS) protocol is illustrated, surgical complications such as postoperative ileus (POI) remain unresolved and significant burden associated leads to suboptimal patients' outcomes of prolonged LOS and physical deconditioning with extended rehabilitation. Prehabilitation refers to optimization in a single or multi-disciplinary approach of exercises training, nutritional therapy and psychological counselling, improves physical fitness, strengthens cardiopulmonary function and reduce mental distress through lifestyle modification and better physiological reserve. However, the concept of educations in form of preoperative exercises and nutritional counselling outweighs the purposes of actual prehabilitation and short-handed allied health professionals limited accessibility of regular out-patient counselling in the current clinical practices. Consequently, poor adherence to these preoperative trainings may result in to poor surgical outcomes.

A single with assessor-blinded, double-armed randomised controlled trial study with a prior pilot will be employed to examine the feasibility and effects of a technology-assisted prehabilitation for patients with colorectal cancer surgery. Outcomes of postoperative complications, LOS, physical activity, nutritional status, gastrointestinal recovery and psychological well-being will be evaluated. Elective colorectal cancer surgery patient will be invited to participated in this study.

The result will provide insights of the use of digital approach. To our knowledge, this is the very first trial of digital prehabilitation for CRC patients in Hong Kong public hospitals. Therefore, it provides positive contribution and acts as an important quality benchmark for patients' outcomes. The findings will also generate knowledge on the optimalization of care provided to CRC patients prior to surgery and assist to develop a structured and effective health system in our community. This innovation may have implications to other research studies and extends the potential clinical practices to related subspecialities such as gastric cancer.

02

Conditions studied

  • Colorectal Cancer (Diagnosis)

Keywords

  • Prehabilitation
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 100 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Tseung Kwan O Hospital, Hong Kong is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of colorectal-related cancer
  • scheduled for elective colorectal cancer surgery as primary treatment
  • aged 18 years or above
  • expected surgery date more than 21 days
  • able to collaborate in the study and sign the informed consent
  • able to use WhatsApp application

Exclusion criteria

Exclusion Criteria:

  • identified or known premorbid, that inability to follow the programme
  • able to understand written and spoken Cantonese/ Chinese
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    WhatsApp-assisted prehabilitation

    Patient will receive WhatsApp-assisted prehabilitation plus standard care

    Other: Intervention · Other: Standard care

  • No intervention
    Standard care

Interventions

  • OtherIntervention

    In addition to standard care, participants will receive digital approach of WhatsApp-assisted prehabilitation programme and then start the home-based training for about 3-4 weeks prior to the surgery. The WhatsApp-assisted prehabilitation includes exercises training, dietary advice and psychological support. Contents will contain elements of physical training (e.g. aerobic and resistance exercises) and psychological therapy (e.g. meditation) will be delivered through WhatsApp at three sessions (day 1, 3 \& 5) per week for 30 minutes and 15 minutes respectively, educational information associated with colorectal cancer surgery and prehabilitation(e.g. high risks factors towards surgical complications) and dietary advices (e.g. recipes) will be delivered on weekly

    Also known as: Prehabilitation

  • OtherStandard care

    Standard care as per department guidelines with ERAS protocol (including smoking cessation program, preoperative counselling, early rehabilitation program)

06

What researchers measure

Primary outcomes

  1. Postoperative complications

    measured by the Comprehensive Complication Index (CCI), which integrates in a single formula all complications by severity, ranging from 0 (uneventful course) to 100 (death).

    Time frame: Postoperative period: assessed up to first year postoperative

Secondary outcomes

  1. Length of hospital stay (LOS)

    to evaluate the length of postoperative hospital stay

    Time frame: Postoperative period: assessed up to the first year postoperative

  2. Physical activity

    measured by the International Physical Activity Questionnaire Short Form (IPAQ-SF), seven items were assessed in frequency and duration over the past seven days, categorizing it into four types: vigorous intensity, moderate intensity, walking, and sitting. An average metabolic equivalents score (MET, min·w-1) was calculated to assess total physical activity as well as for each type of activity, separately. For walking activities, all types of walking were included and an average MET score was derived. The same procedure was carried out for medium intensity and high intensity activities. By calculating the number of activity days multiplied by the average duration per activity, statements about the energy consumption per week and the fitness level can be derived.

    Time frame: Assessments at baseline, weekly before the surgery and on the day of discharge: assess up to first year postoperative

  3. Gastrointestinal recovery

    measured as time to first flatus (in hours)

    Time frame: Postoperative period: assessed up to 30 days postoperative

  4. Gastrointestinal function

    measured as time to first bowel (hours)

    Time frame: Postoperative period: assess up to 30 days postoperative

  5. Anxiety and depression

    assessed by the Chinese version of Hospital Anxiety and Depression Scale (C-HADS), a 14-question measure with seven items each for depression and anxiety. HADS generates separate scores for anxiety and depression as well as a combined score of psychological distress. Continuos variable 0-21 (0-7 normal value, 11-21 anxiety/depression), higher value from baseline will represent a worse outcome.

    Time frame: Assessments at baseline and on the day of discharge: assess up to first year postoperative

  6. Quality of health-related life

    evaluated by the Short Form 12 Health Survey (SF-12 version 2 (Hong Kong)), with Physical Component Summary (PCS) and Mental Component Summary (MCS). Scores range from 0-100 for the 8 underlying health domains, with higher scores meaning better Health-Related Quality of Life (HRQoL)

    Time frame: Assessments at baseline and on the day of discharge: assess up to first year postoperative

Other outcomes

  1. Adherence to the prehabilitation

    percentage of completed at least 75% of the prehabilitation.

    Time frame: From enrollment to the completion of study up to 18 months

07

Study locations

1 site
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Jan 12, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07376668
Lead sponsor
Tseung Kwan O Hospital, Hong Kong
Collaborators
Chinese University of Hong Kong
Responsible party
SUNG HOI LING SHERING (Principal Investigator, Tseung Kwan O Hospital, Hong Kong) — Principal investigator
First posted
Jan 29, 2026
Start date
Jan 15, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Feb 3, 2026

Study contacts

SHERING SUNG
Contact
sheringsung@link.cuhk.edu.hk
85222080980
SHERING SUNG
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion